Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include: Progressive microcephaly, Hypertonia, Axial hypotonia, and Hypsarrhythmia and 12 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 4 | Seizure, Global developmental delay, Depressed nasal bridge |
Head and neck |
MDH1 encodes malate dehydrogenase 1 (334 aa). Catalyzes the reduction of aromatic alpha-keto acids in the presence of NADH. Highest expression in Heart Left Ventricle (440.0 TPM) and Brain Frontal Cortex BA9 (377.3 TPM).
Developmental and epileptic encephalopathy, 88 is associated with mutations in the MDH1 gene on chromosome 2.
The MDH1 protein participates in GOT2 transaminates OA and L-Glu and Malate-aspartate shuttle pathways.
MDH1 is classified as a druggable target (Enzyme category) with score 0.0.
Genetic testing for MDH1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for developmental and epileptic encephalopathy, 88 has been reported in the published literature.
No clinical trials have been registered for developmental and epileptic encephalopathy, 88.
42 publications have been identified in PubMed for developmental and epileptic encephalopathy, 88. Research spans Epidemiology / Natural History (26%), Diagnostic / Biomarker (14%), and Review / Meta-Analysis (14%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 11 | 26% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 6:07 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
2 |
Progressive microcephaly, Everted lower lip vermilion |
Muscles | 1 | Axial hypotonia |
Growth and development | 1 | Growth delay |
Testing and diagnosis research |
6 |
14% |
Research summaries | 6 | 14% |
Patient case studies | 6 | 14% |
Clinical study results | 5 | 12% |
Laboratory research | 5 | 12% |
Other research | 2 | 5% |
New treatment approaches | 1 | 2% |
Pujee BK (2026). [PMID: 42078625](https://pubmed.ncbi.nlm.nih.gov/42078625/). *Ann Med Surg (Lond)*. [Case Report / Case Series]
Cioclu MC (2026). [PMID: 42112912](https://pubmed.ncbi.nlm.nih.gov/42112912/). *Epilepsia Open*. [Review / Meta-Analysis]
Macdonald-Laurs E (2026). [PMID: 41025997](https://pubmed.ncbi.nlm.nih.gov/41025997/). *Epilepsia*. [Diagnostic / Biomarker]
Hainlen M (2026). [PMID: 41481933](https://pubmed.ncbi.nlm.nih.gov/41481933/). *J Neurosci Nurs*. [Other]
Feng W (2026). [PMID: 42247924](https://pubmed.ncbi.nlm.nih.gov/42247924/). *Seizure*. [Case Report / Case Series]
Liogier d'Ardhuy X (2026). [PMID: 41531035](https://pubmed.ncbi.nlm.nih.gov/41531035/). *Epilepsia*. [Epidemiology / Natural History]
Biagioni T (2026). [PMID: 41663195](https://pubmed.ncbi.nlm.nih.gov/41663195/). *Arch Dis Child Fetal Neonatal Ed*. [Diagnostic / Biomarker]
Mondragon E (2026). [PMID: 41215607](https://pubmed.ncbi.nlm.nih.gov/41215607/). *Epilepsia*. [Clinical Trial Publication]
Briscoe C (2026). [PMID: 41172580](https://pubmed.ncbi.nlm.nih.gov/41172580/). *Pediatr Neurol*. [Review / Meta-Analysis]
Myaka-Gama A (2026). [PMID: 41809399](https://pubmed.ncbi.nlm.nih.gov/41809399/). *Afr J Disabil*. [Clinical Trial Publication]